GSK press releases Follow Nucala significantly reduces exacerbations in first global prospective real-world study of a biologic in severe eosinophilic asthma Results from interim analysis of REALITI-A study presented at ERS conference https://www.gsk.com/en-gb/media/press-releases/nucala-significantly-reduces-exacerbations-in-first-global-prospective-real-world-study-of-a-biologic-in-severe-eosinophilic-asthma/ gsk.com
